A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2007
12/05/2007	EP1485359B1 Sodium channel blockers
12/05/2007	EP1272458B1 Arginine mimetics as factor xa inhibitors
12/05/2007	EP1137642B1 Bis-sulfonamides
12/05/2007	CN101081255A kazukiyo oral liquid agent and its preparing process
12/05/2007	CN101081251A Polygonum multiflorum thunb processing method
12/05/2007	CN101081250A Potygonum multiflorum thunb extract medicament for treating anemia and the preparing method thereof
12/05/2007	CN101081242A Notoginseng extract for treating cardiovascular disease and method for making same
12/05/2007	CN101081229A Plasma subtitute injection using hydroxyethyl group amylum as blood plasma dilatancy agent
12/05/2007	CN100352831C Burnet general saponin extract , its preparation method and use
12/05/2007	CN100352816C Nociceptin analogs
12/05/2007	CN100352807C Chemical compounds
12/05/2007	CN100352804C 酰胺衍生物 Amide derivatives
12/05/2007	CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor
12/05/2007	CN100352493C Method of treating tumors
12/05/2007	CN100352471C Medication for curing secondary anemia, iron deficiency anemia and preparation method
12/05/2007	CN100352442C Pharmaceutical combinations
12/04/2007	US7304083 2-iminoimidazole derivatives (2)
12/04/2007	US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders
12/04/2007	US7304066 Pyridyl cyanoguanidine compounds
12/04/2007	US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007	US7303890 Proteins, genes encoding them and method of using the same
12/04/2007	US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof
12/04/2007	US7303758 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices
11/2007
11/29/2007	WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007	WO2007136689A2 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/29/2007	WO2007136641A2 Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute
11/29/2007	WO2007136085A1 Spiro tetracyclic compound
11/29/2007	WO2007135182A2 Factor ix analogues having prolonged in vivo half life
11/29/2007	WO2007134813A2 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
11/29/2007	WO2007134617A1 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
11/29/2007	WO2007042469A3 Anticoagulant antithrombotic dual inhibitors comprising a biotin label
11/29/2007	WO2006133955A8 Adamts13-comprising compositions having thrombolytic activity
11/29/2007	US20070276128 Stabilized Proteins with Engineered Disulfide Bonds
11/29/2007	US20070276015 Crystal modification of torasemide
11/29/2007	US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007	US20070275922 RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
11/29/2007	US20070275913 Compositions and their uses directed to hepcidin
11/29/2007	US20070275882 Nature-Identical Erythropoietin
11/29/2007	US20070275880 Virally-Safe Factor VIII with a Low Content of Higher Multimers
11/29/2007	US20070275050 Method for treating blood coagulation disorders
11/29/2007	DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators
11/29/2007	CA2657965A1 Methods of treating acute blood loss
11/29/2007	CA2653154A1 Prolonged fix analogues and derivatives
11/29/2007	CA2651487A1 Methods for treating chemotherapy and radiation therapy side effects
11/29/2007	CA2651420A1 Spiro tetracyclic compound
11/29/2007	CA2646081A1 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/29/2007	CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/28/2007	EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007	EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007	EP1859834A1 Anti-inflammatory agent
11/28/2007	EP1859679A1 Protective solution for preventing ischaemia damage
11/28/2007	EP1858890A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
11/28/2007	EP1858541A2 Use of modulators of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism
11/28/2007	EP1858355A1 High pressure processing of metal ion lactoferrin
11/28/2007	EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007	EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007	CN101080407A Crystalline forms of a factor XA inhibitor
11/28/2007	CN101077414A Medicine new use for liver hydrolysis-peptide
11/28/2007	CN101077376A Traditional Chinese medicine decoction
11/28/2007	CN101077372A Chinese medicinal materials composition for preventing and treating iron-deficiency anemia and method of making the same
11/28/2007	CN101077356A Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine and other medicines
11/28/2007	CN101077179A Golden mushroom intelligence developmental porridge
11/28/2007	CN101077178A Nutritive health-care food and its making method
11/28/2007	CN101077170A Special purpose seasoning oil for barbecue and and preparation method thereof
11/28/2007	CN101077148A 胡桃小米粥 Walnut millet gruel
11/28/2007	CN101077112A 板蓝根茶及其制备方法 Radix tea and its preparation method
11/28/2007	CN101077108A Health-care tea and its preparing process
11/28/2007	CN100351381C Novel thrombase-like gene and its use
11/28/2007	CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007	CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007	CN100351244C Bis-aromatic alkanols
11/28/2007	CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007	CN100350914C Medicinal composition for antipyretic, analgesic, anti-inflammatory and anti platelet aggregation
11/27/2007	US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007	US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007	US7300674 Sterile low bicarbonate dialysis concentrate solutions
11/27/2007	US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007	CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007	CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/27/2007	CA2267932C Compositions for postgastrectomic mineral supply
11/22/2007	WO2007131973A2 Compositions and methods for modulating the immune system
11/22/2007	WO2007131280A1 HEMATOPOIESIS AND REGULATION THEREOF BY ETS RELATED GENE (Erg)
11/22/2007	WO2007093608A8 Drug combinations for the treatment of respiratory tract diseases
11/22/2007	WO2002047726A3 Pharmaceutical composition containing an active with a hemolytic action and a surfactant
11/22/2007	US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007	US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007	US20070270342 Biotinylated hexadecasaccharides, preparation and use thereof
11/22/2007	US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007	US20070269484 Drug-delivery stent formulations for restenosis and vulnerable plaque
11/22/2007	DE102006021733A1 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung 3 Tetrazolylindazole and 3-Tetrazolylpyrazolopyridine and their use
11/22/2007	CA2653753A1 Substituted prolinamides, production thereof and their use as medicaments
11/22/2007	CA2652235A1 Methods for treating blood disorders
11/22/2007	CA2651623A1 Compositions and methods for modulating the immune system
11/21/2007	EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007	EP1857110A2 Hormone replacement therapy
11/21/2007	EP1856147A1 A molecule and chimeric molecules thereof
11/21/2007	EP1856104A1 Processes and compounds for the preparation of substituted naphthylindole derivatives
11/21/2007	EP1856037A1 Amidino-compounds for stabilizing factor vii polypeptide formulations

1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 671